Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2025 | 1 | -$2.66 | -$2.66 | -$2.66 |
| Q4 2025 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q1 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2026 | 1 | -$0.96 | -$0.96 | -$0.96 |
| Q3 2026 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q4 2026 | 1 | -$0.87 | -$0.87 | -$0.87 |
Quantum BioPharma Ltd. last posted its earnings results on Friday, November 7th, 2025. The company reported $-1.25 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $1.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Quantum BioPharma Ltd. has generated $-12 earnings per share over the last year ($-12.49 diluted earnings per share) and currently has a price-to-earnings ratio of -1.12. Quantum BioPharma Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 26th, 2026 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 2025 | N/A | -$1.25 | N/A | $889.59 K | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$3.23 | N/A | $2.89 M | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$7.52 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$5.22 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$4.17 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$4.85 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$3.12 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$2.18 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$1.76 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$9.10 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$16.61 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | -$10.29 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$12.13 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$7.47 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$9.60 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$11.01 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$10.37 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$23.85 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$24.02 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$15.25 | N/A | N/A | $0 |
Quantum BioPharma Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 26th, 2026 based offlast year's report dates.
The conference call for Quantum BioPharma Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Quantum BioPharma Ltd.'s latest earnings report can be read online.
Quantum BioPharma Ltd. (:QNTM) has a recorded net income of $-14,202,724.Quantum BioPharma Ltd. has generated $-12.49 earnings per share over the last four quarters.
Quantum BioPharma Ltd. (:QNTM) has a price-to-earnings ratio of -1.12 and price/earnings-to-growth ratio is -0.15.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED